Cell-mediated immune responses to COPV early proteins
- 1 September 2006
- Vol. 356 (1-2) , 23-34
- https://doi.org/10.1016/j.virol.2006.07.032
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Carcinogenicity of human papillomavirusesThe Lancet Oncology, 2005
- Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialThe Lancet, 2004
- Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6Cancer Research, 2004
- Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and InfectionJournal of Virology, 2004
- Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident InfectionThe Journal of Infectious Diseases, 2000
- Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasiaJournal of General Virology, 1999
- Vaccination against papillomavirus in cattleClinics in Dermatology, 1997
- Immunological Events in Regressing Genital WartsAmerican Journal of Clinical Pathology, 1994
- Humoral Immune Response to the E7 Protein of Bovine Papillomavirus Type 4 and Identification of B-Cell EpitopesVirology, 1994
- Skin Test to Assess Immunity Against Cottontail Rabbit Papillomavirus Antigens in Rabbits with Progressing Papillomas or After Papilloma RegressionJournal of Investigative Dermatology, 1993